Angiographic findings in cases with a history of severe retinopathy of prematurity treated with anti-VEGFs: Follow-up to age 6 years
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiographic findings in cases with a history of severe retinopathy of prematurity treated with anti-VEGFs: Follow-up to age 6 years
Authors
Keywords
-
Journal
INTERNATIONAL OPHTHALMOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-03
DOI
10.1007/s10792-021-02119-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Study protocol for prognosis and treatment strategy of peripheral persistent avascular retina after intravitreal anti-VEGF therapy in retinopathy of prematurity
- (2020) Ying Yu et al. Trials
- Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression
- (2019) Aslı Vural et al. INTERNATIONAL OPHTHALMOLOGY
- Persistent Avascular Retina in Infants With a History of Type 2 Retinopathy of Prematurity: To Treat or Not to Treat?
- (2019) Rasha Al-Taie et al. JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
- Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings
- (2018) Domenico Lepore et al. OPHTHALMOLOGY
- Findings in Persistent Retinopathy of Prematurity
- (2018) Clinton C. Warren et al. Ophthalmic Surgery Lasers & Imaging Retina
- Late ROP Reactivation and Retinal Detachment in a Teenager
- (2018) Liliya Golas et al. Ophthalmic Surgery Lasers & Imaging Retina
- Screening Examination of Premature Infants for Retinopathy of Prematurity
- (2018) Walter M. Fierson et al. PEDIATRICS
- PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY
- (2017) Jose M. Garcia Gonzalez et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY
- (2017) Birgit Lorenz et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity
- (2016) Brian C. Toy et al. OPHTHALMOLOGY
- Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab
- (2016) Laura L. Snyder et al. Ophthalmic Surgery Lasers & Imaging Retina
- New insights in diagnosis and treatment for Retinopathy of Prematurity
- (2016) Linda A. Cernichiaro-Espinosa et al. INTERNATIONAL OPHTHALMOLOGY
- Influence of Fluorescein Angiography on the Diagnosis and Management of Retinopathy of Prematurity
- (2015) Michael A. Klufas et al. OPHTHALMOLOGY
- Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity
- (2015) Christopher K. Hwang et al. OPHTHALMOLOGY
- REACTIVATION OF RETINOPATHY OF PREMATURITY AFTER RANIBIZUMAB TREATMENT
- (2015) Ryan K. Wong et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity
- (2014) Sjakon G Tahija et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity — 27 month follow-up results from Turkey
- (2014) Huseyin Yetik et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal Bevacizumab versus Laser Treatment in Type 1 Retinopathy of Prematurity
- (2014) Domenico Lepore et al. OPHTHALMOLOGY
- Intravitreal low-dosage bevacizumab for retinopathy of prematurity
- (2013) Björn C. Harder et al. ACTA OPHTHALMOLOGICA
- Exudative retinopathy and detachment: A late reactivation of retinopathy of prematurity after intravitreal bevacizumab
- (2013) Shaun Ittiara et al. JOURNAL OF AAPOS
- An Updated Study of the Use of Bevacizumab in the Treatment of Patients with Prethreshold Retinopathy of Prematurity in Taiwan
- (2012) Wei-Chi Wu et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Significant Treatment Failure With Intravitreous Bevacizumab for Retinopathy of Prematurity
- (2012) Ravi D. Patel et al. ARCHIVES OF OPHTHALMOLOGY
- Reactivation of Retinopathy of Prematurity After Bevacizumab Injection
- (2012) Jennifer Hu et al. ARCHIVES OF OPHTHALMOLOGY
- Fluorescein angiography to estimate normal peripheral retinal nonperfusion in children
- (2012) Michael P. Blair et al. JOURNAL OF AAPOS
- Fluorescein angiography and retinal vascular development in premature infants
- (2012) Purcaro Velia et al. Journal of Maternal-Fetal & Neonatal Medicine
- Changes in causes of low vision between 1988 and 2009 in a Dutch population of children
- (2011) Nienke Boonstra et al. ACTA OPHTHALMOLOGICA
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
- (2011) Helen A. Mintz-Hittner et al. NEW ENGLAND JOURNAL OF MEDICINE
- MANAGEMENT OF AVASCULAR PERIPHERAL RETINA IN OLDER PREMATURELY BORN INFANTS
- (2011) Lawrence Y Ho et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Atlas of Fluorescein Angiographic Findings in Eyes Undergoing Laser for Retinopathy of Prematurity
- (2010) Domenico Lepore et al. OPHTHALMOLOGY
- A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity
- (2009) Jonathan A. Micieli et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Vascular Abnormalities in Aggressive Posterior Retinopathy of Prematurity Detected by Fluorescein Angiography
- (2009) Tadashi Yokoi et al. OPHTHALMOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started